Literature DB >> 25453298

Antidiabetic medications and polypharmacy.

Emily P Peron1, Kelechi C Ogbonna2, Krista L Donohoe3.   

Abstract

Polypharmacy, or the use of multiple medications, is a serious concern for providers who care for older adults, as polypharmacy is associated with medication nonadherence, drug-drug interactions, drug-disease interactions, and adverse drug events. Multiple medications, high chronic disease burden, and age-related physiologic changes make management of older adults with diabetes increasingly difficult. Given high medication burden and potential for increased medication sensitivity in this patient population, it is prudent that providers are aware of potential risks and benefits of antidiabetic medications and implement shared decision-making practices to ensure appropriate care for older adults with diabetes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adverse drug events; Diabetic complications; Geriatric syndromes; Hypoglycemic agents; Polypharmacy

Mesh:

Substances:

Year:  2014        PMID: 25453298      PMCID: PMC4860345          DOI: 10.1016/j.cger.2014.08.017

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN: 0749-0690            Impact factor:   3.076


  36 in total

1.  Using clinical guidelines designed for older adults with diabetes mellitus and complex health status.

Authors:  Samuel C Durso
Journal:  JAMA       Date:  2006-04-26       Impact factor: 56.272

2.  Potential pitfalls of disease-specific guidelines for patients with multiple conditions.

Authors:  Mary E Tinetti; Sidney T Bogardus; Joseph V Agostini
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

3.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

4.  The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: the Rancho Bernardo study.

Authors:  Nicole M Wedick; Elizabeth Barrett-Connor; James D Knoke; Deborah L Wingard
Journal:  J Am Geriatr Soc       Date:  2002-11       Impact factor: 5.562

Review 5.  European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary.

Authors:  Alan J Sinclair; Giuseppe Paolisso; Marta Castro; Isabelle Bourdel-Marchasson; Roger Gadsby; Leocadio Rodriguez Mañas
Journal:  Diabetes Metab       Date:  2011-11       Impact factor: 6.041

6.  Strategies for prevention of medication-related falls in the elderly.

Authors:  R Blake Keller; Patricia W Slattum
Journal:  Consult Pharm       Date:  2003-03

Review 7.  Optimising drug treatment for elderly people: the prescribing cascade.

Authors:  P A Rochon; J H Gurwitz
Journal:  BMJ       Date:  1997-10-25

Review 8.  Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

Authors:  Kjeld Hermansen; Lene S Mortensen
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Silvio E Inzucchi; Richard M Bergenstal; John B Buse; Michaela Diamant; Ele Ferrannini; Michael Nauck; Anne L Peters; Apostolos Tsapas; Richard Wender; David R Matthews
Journal:  Diabetes Care       Date:  2012-04-19       Impact factor: 19.112

10.  Predicting 6-year mortality risk in patients with type 2 diabetes.

Authors:  Brian J Wells; Anil Jain; Susana Arrigain; Changhong Yu; Wayne A Rosenkrans; Michael W Kattan
Journal:  Diabetes Care       Date:  2008-09-22       Impact factor: 17.152

View more
  16 in total

Review 1.  Clinically and pharmacologically relevant interactions of antidiabetic drugs.

Authors:  Marcus May; Christoph Schindler
Journal:  Ther Adv Endocrinol Metab       Date:  2016-03-31       Impact factor: 3.565

Review 2.  Diabetes Treatment in the Elderly: Incorporating Geriatrics, Technology, and Functional Medicine.

Authors:  Willy Marcos Valencia; Diana Botros; Maria Vera-Nunez; Stuti Dang
Journal:  Curr Diab Rep       Date:  2018-09-05       Impact factor: 4.810

3.  Evaluation of hepatic CYP2D1 activity and hepatic clearance in type I and type II diabetic rat models, before and after treatment with insulin and metformin.

Authors:  Navid Neyshaburinezhad; Maryam Seidabadi; Mohammadreza Rouini; Hoda Lavasani; Alireza Foroumadi; Yalda H Ardakani
Journal:  Daru       Date:  2020-05-06       Impact factor: 3.117

4.  Polypharmacy among patients with diabetes: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia.

Authors:  Monira Alwhaibi; Bander Balkhi; Tariq M Alhawassi; Hadeel Alkofide; Nouf Alduhaim; Rawan Alabdulali; Hadeel Drweesh; Usha Sambamoorthi
Journal:  BMJ Open       Date:  2018-05-24       Impact factor: 2.692

5.  Influence of aprepitant on the pharmacodynamics and pharmacokinetics of gliclazide in rats and rabbits.

Authors:  Raghunandan Reddy Kura; Eswar Kumar Kilari; Mastan Shaik
Journal:  PeerJ       Date:  2018-05-22       Impact factor: 2.984

6.  Polypharmacy, potentially serious clinically relevant drug-drug interactions, and inappropriate medicines in elderly people with type 2 diabetes and their impact on quality of life.

Authors:  Labib Al-Musawe; Carla Torre; Jose Pedro Guerreiro; Antonio Teixeira Rodrigues; Joao Filipe Raposo; Helder Mota-Filipe; Ana Paula Martins
Journal:  Pharmacol Res Perspect       Date:  2020-08

7.  Reevaluating the Evidence for Blood Pressure Targets in Type 2 Diabetes.

Authors:  Julio A Lamprea-Montealegre; Ian H de Boer
Journal:  Diabetes Care       Date:  2018-06       Impact factor: 19.112

Review 8.  Chronic Inflammatory Status Observed in Patients with Type 2 Diabetes Induces Modulation of Cytochrome P450 Expression and Activity.

Authors:  Lucy Darakjian; Malavika Deodhar; Jacques Turgeon; Veronique Michaud
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

9.  Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy.

Authors:  Arseniy P Yashkin; Julia Kravchenko; Anatoliy I Yashin; Frank Sloan
Journal:  Am J Hypertens       Date:  2018-01-12       Impact factor: 3.080

10.  Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: Diabetic Treatment Burden Questionnaire (DTBQ).

Authors:  Hitoshi Ishii; Koki Shin; Takahiro Tosaki; Tatsuya Haga; Yoshiki Nakajima; Toshihiko Shiraiwa; Nobuaki Watanabe; Miyuki Koizumi; Hiroki Nakajima; Sadanori Okada; Tsuyoshi Mashitani; Takako Mohri; Yasuhiro Akai
Journal:  Diabetes Ther       Date:  2018-03-29       Impact factor: 2.945

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.